Effects of Chronic GM1 Ganglioside Treatment on Nigral Dopamine Cell Bodies and Dendrites in Experimental Rats Using Image Analysis — Relationship to the Pharmacokinetic Properties

  • Luigi F. Agnati
  • Kjell Fuxe
  • Gino Toffano
  • Laura Calza
  • Isabella Zini
  • Luciana Giardino
  • Franco Mascagni
  • Menek Goldstein
Part of the Wenner-Gren Center International Symposium Series book series (WGCISS, volume 42)

Abstract

Previous studies have shown that chronic treatment with the GM1 ganglioside can increase the survival of dopamine nerve cell bodies in the substantia nigra, mainly in the caudal part on the lesioned side, following a partial unilateral hemitransection (Agnati et al. 1983, 1984; Toffano et al. 1983). It was also demonstrated that chronic treatment with the ganglioside GM1 increase tyrosine hydroxylase immunoreactivity within the rostrally located dopamine nerve cells present close to the site of the lesion (Agnati et al. 1984). Also it was found that chronic GM1 ganglioside treatment increases the density of tyrosine hydroxylase immunoreactive dendrites in the zona reticulata of the lesioned side as shown at several rostrocaudal levels. These results were interpreted to indicate that chronic GM1 treatment can exert an excitatory metabolic action on dopamine nerve cells present close to the lesion which may lead to enhanced production of neuronal trophic factors diffusing out in the substantia nigra and causing an increased survival of the less severely lesioned dopamine nerve cells present within the caudal part of the substantia nigra (see Agnati et al. 1984).

Keywords

Dopamine Cage Tyrosine Heparin Tritium 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Agnati, L.F., Fuxe, K., Calza, L., Goldstein, M., Toffano, G., Giardino, L. and Zoli, M. (1984). Computer assisted morphometry and microdensitometry of transmitter identified neurons with special reference to the mesostriatal dopamine pathway. II. Further studies on the effects of the GM1 ganglioside on the degenerative and regenerative features of mesostriatal dopamine neurons. Acta Physiol Scand., Suppl. 532; 37–42.Google Scholar
  2. Agnati, L.F., Fuxe, K., Calza, L., Benfenati, F., Cavicchioli, L., Toffano, G. and Goldstein, M. (1983). Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopamnergic synaptic function in striatum of rats by collateral sprouting. Acta Physiol Scand.199, 347–363.CrossRefGoogle Scholar
  3. Hollander, M. and Wolfe, D.A. (1973). Non-parametric statistical methods. Wiley, New York.Google Scholar
  4. Markey, K. A., Kondo, S., Shenkman, L. and Goldstein, M. (1980). Purification and characterization of tyrosine hydroxylase from a clonal chromocytoma cell line. Mol Pharmacol 17, 79–85.PubMedGoogle Scholar
  5. Sternberger, L.A. (1979). Immunocytochemistry. 2nd ed., Wiley, New York.Google Scholar
  6. Toffano, G., Savoini, G., Moroni, F., Lombardi, G., Calza, L. and Agnati, L.F. (1983). GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system. Brain Res., 261, 163–166.PubMedCrossRefGoogle Scholar

Copyright information

© The Wenner-Gren Centre 1985

Authors and Affiliations

  • Luigi F. Agnati
    • 1
  • Kjell Fuxe
    • 2
  • Gino Toffano
    • 3
  • Laura Calza
    • 1
  • Isabella Zini
    • 1
  • Luciana Giardino
    • 1
  • Franco Mascagni
    • 1
  • Menek Goldstein
    • 4
  1. 1.Department of Human PhysiologyUniversity of ModenaModenaItaly
  2. 2.Department of HistologyKarolinska InstitutetStockholmSweden
  3. 3.Department of BiochemistryFidia Research LaboratoriesItaly
  4. 4.New York University Medical CenterNew YorkUSA

Personalised recommendations